Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8 Regulatory T Cells.

Neurol Neuroimmunol Neuroinflamm

From the Nantes Université (N.B., B.N., J.L., S.B., L.F., H.R., N.V., S.R., A.G., I.A., D.L., C.G.), INSERM, CNRS, Center for Research in Transplantation et Translational Immunology, UMR 1064; and CHU Nantes (F.L.F.), Nantes Université, Service de Neurologie, Centre de Ressources et de Compétences Sclérose en Plaques, Nantes, France.

Published: November 2022

Background And Objectives: Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the CNS. Studies of immune dysfunction in MS have mostly focused on CD4 Tregs, but the role of CD8 Tregs remains largely unexplored. We previously evidenced the suppressive properties of rat and human CD8CD45RC Tregs from healthy individuals, expressing Forkhead box P3 (FOXP3) and acting through interferon-gamma (IFN-γ), transforming growth factor beta (TGFβ), and interleukin-34 (IL-34). secretions to regulate immune responses and control diseases such as transplant rejection. To better understand CD8CD45RC Tregs contribution to MS pathology, we further investigated their phenotype, function, and transcriptome in patients with MS.

Methods: We enrolled adults with relapsing-remitting MS and age-matched and sex-matched healthy volunteers (HVs). CD8 T cells were segregated based on low or lack of expression of CD45RC. First, the frequency in CSF and blood, phenotype, transcriptome, and function of CD8CD45RC and were investigated according to exacerbation status and secondarily, according to clinical severity based on the MS severity score (MSSS) in patients with nonexacerbating MS. We then induced active MOG EAE in C57Bl/6 mice and performed adoptive transfer of fresh and expanded CD8CD45RC Tregs to assess their ability to mitigate neuroinflammation in vivo.

Results: Thirty-one untreated patients with relapsing-remitting MS were compared with 40 age-matched and sex-matched HVs. We demonstrated no difference of CSF CD8CD45RC and CD8CD45RC proportions, but blood CD8CD45RC frequency was lower in patients with MS exacerbation when compared with that in HVs. CD8CD45RC Tregs but not CD8CD45RC showed higher suppressive capacities in vitro in MS patients with exacerbation than in patients without acute inflammatory attack. In vitro functional assays showed a compromised suppression capacity of CD8CD45RC Tregs in patients with nonexacerbating severe MS, defined by the MSSS. We then characterized murine CD8CD45RC Tregs and demonstrated the potential of CD45RC cells to migrate to the CNS and mitigate experimental autoimmune encephalomyelitis in vivo.

Discussion: Altogether, these results suggest a defect in the number and function of CD8CD45RC Tregs during MS relapse and an association of CD8CD45RC Tregs dysfunction with MS severity. Thus, CD8CD45RC T cells might bring new insights into the pathophysiology and new therapeutic approaches of MS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621606PMC
http://dx.doi.org/10.1212/NXI.0000000000200016DOI Listing

Publication Analysis

Top Keywords

cd8cd45rc tregs
32
cd8cd45rc
14
tregs
10
patients
8
multiple sclerosis
8
age-matched sex-matched
8
function cd8cd45rc
8
patients nonexacerbating
8
patients exacerbation
8
patients severe
4

Similar Publications

CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.

J Clin Invest

April 2007

INSERM U643, Centre Hopitalier Universitaire de Nantes, Institut de Transplantation et de Recherche en Transplantation (ITERT), and Université de Nantes, Faculté de Médecine, Nantes, France.

Treatment with CD40Ig results in indefinite allograft survival in a complete MHC-mismatched heart allograft model in the rat. Here we show that serial second, third, and fourth adoptive transfers of total splenocytes from CD40Ig-treated recipients into secondary recipients led to indefinite donor-specific allograft acceptance. Purification of splenocyte subpopulations from CD40Ig-treated recipients demonstrated that only the adoptively transferred CD8(+)CD45RC(low) subset resulted in donor-specific long-term survival, whereas CD8(+)CD45RC(low) T cells from naive animals did not.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!